Case Details
- Citation: [2017] SGHC 143
- Title: Ang Peng Tiam v Singapore Medical Council and another matter
- Court: High Court of the Republic of Singapore
- Date of Decision: 27 June 2017
- Judges (Coram): Sundaresh Menon CJ; Andrew Phang Boon Leong JA; Judith Prakash JA
- Case Numbers: Originating Summonses Nos 8 and 9 of 2016
- Parties: Ang Peng Tiam (appellant/applicant) v Singapore Medical Council and another matter (respondent)
- Procedural Posture: Two appeals: (1) Dr Ang appealed against conviction on two charges; (2) the SMC appealed against sentence as manifestly inadequate
- Legal Area: Professions — Medical profession and practice — Professional conduct
- Key Statutory Provision: s 53(1)(d) of the Medical Registration Act (Cap. 174, 2004 Rev Ed) (professional misconduct)
- Tribunal Below: Disciplinary Tribunal appointed by the Singapore Medical Council
- Charges Upheld: Two charges of professional misconduct (the remaining two charges were acquitted; no appeal against acquittal)
- Sentence Imposed by DT: Aggregate fine of S$25,000 for both charges
- Representation: Edwin Tong, S.C., Mak Wei Munn, Tan Ruyan Kristy and Ong Hui Fen Rachel (Allen & Gledhill LLP) for the appellant in OS 8/2016 and respondent in OS 9/2016; Ho Pei Shien Melanie, Lim Xian Yong Alvin, Lim Wan Yu Cheronne, Chang Man Phing Jenny, and Lim Ying Min (Wongpartnership LLP) for the respondent in OS 8/2016 and appellant in OS 9/2016
- Judgment Length: 32 pages; 19,988 words
- Cases Cited (as provided): [2017] SGCA 38; [2017] SGHC 143
Summary
In Ang Peng Tiam v Singapore Medical Council [2017] SGHC 143, the High Court considered appeals arising from a Disciplinary Tribunal’s finding that Dr Ang Peng Tiam, a private practice oncologist, committed professional misconduct under s 53(1)(d) of the Medical Registration Act (Cap. 174). The DT convicted Dr Ang on two charges: first, that he made a false representation to a patient about the likelihood of disease control with chemotherapy and targeted therapy; and second, that he failed to offer surgery as an alternative treatment option.
The High Court approached the case by examining (i) how the patient would objectively understand the doctor’s statements in context, (ii) whether the doctor had a reasonable basis for the impugned representation, and (iii) whether the failure to offer surgery amounted to an intentional, deliberate departure from professional standards. The Court also addressed the SMC’s appeal that the DT’s fine was manifestly inadequate, and it considered the appropriate sentencing response for serious breaches affecting patient decision-making.
What Were the Facts of This Case?
Dr Ang was an oncologist practising at Parkway Cancer Centre (“PCC”). The patient, MT, was 55 years old and was referred for investigations after findings at Tan Tock Seng Hospital suggested possible lung cancer. On 30 March 2010, MT consulted Dr Ang. He ordered blood tests and imaging including an MRI of the brain and a PET-CT scan. However, he did not order an epidermal growth factor receptor (“EGFR”) analysis to determine MT’s EGFR mutation status, even though EGFR status was material to the effectiveness of certain targeted therapies.
On 31 March 2010, MT returned to review results. Dr Ang explained the PET-CT findings in detail to MT and her family. The PET-CT suggested a large, fast-growing and aggressive tumour, with central necrosis and “satellite nodules”. Dr Ang also informed them that the MRI did not show metastatic disease in the brain and that a biopsy was needed to confirm whether the mass was cancerous. The biopsy was performed later that day.
On 1 April 2010, MT attended a third consultation. The biopsy confirmed cancer, diagnosed as adenocarcinoma. Dr Ang recommended chemotherapy (gemcitabine and cisplatin) together with targeted therapy using gefitinib (Iressa) on an alternate-day dosage. During this consultation, Dr Ang conveyed to MT and her family—through an explanation that was partially recorded by MT’s husband—that there was “at least a 70% chance” the tumour would shrink and that this was a “very high percentage”. The translation of the recording included a persuasive analogy and an emphasis on the high likelihood of response. The Court noted that the contents of the recording, as translated, were not disputed.
Crucially, Dr Ang’s assessment of a 70% chance of disease control was premised on four “phenotypes”: that MT was Chinese, female, a “never-smoker”, and had adenocarcinoma. Dr Ang documented these factors in a memo for MT and her family, including “70%” circled and additional markings intended to indicate a large tumour expected to shrink. MT proceeded with the recommended treatment. Unfortunately, her disease did not respond well; it progressed and she died a little more than six months later in October 2010.
After MT’s death, MT’s two daughters lodged a complaint with the Singapore Medical Council on 15 December 2010. The complaints process was protracted. The Complaints Committee wrote to Dr Ang in June 2011 requesting his explanation, which he provided in July 2011. However, it took until May 2012 for Dr Ang to receive notice that the matter would be referred to a formal inquiry. The constitution of the Disciplinary Tribunal was delayed further, with a second DT only constituted on 3 April 2015. A Notice of Inquiry specifying the charges was served on 22 April 2015. The DT heard the inquiry in two tranches between November 2015 and February 2016 and delivered its verdict on conviction and sentence on 12 July 2016—more than five and a half years after the complaint was lodged.
What Were the Key Legal Issues?
The first major issue was whether Dr Ang’s statement to MT—namely that there was at least a “70% chance” of disease control with chemotherapy and/or targeted therapy—constituted a “false representation” amounting to professional misconduct under s 53(1)(d). This required the Court to consider the meaning of the statement from the perspective of a reasonable patient in context, and whether the statement was false because it was not supported by the necessary clinical basis, particularly MT’s EGFR mutation status.
The second issue concerned the second charge: whether Dr Ang’s failure to offer surgery as an alternative treatment option amounted to professional misconduct. This required the Court to examine what the professional standard required in the circumstances, and whether the omission reflected an intentional, deliberate departure from standards observed or approved by members of the profession of good repute and competence.
Finally, because the SMC appealed against sentence, the Court had to consider whether the DT’s aggregate fine of S$25,000 was manifestly inadequate. This involved assessing the seriousness of the misconduct, its impact on patient autonomy and decision-making, and the sentencing principles applicable to disciplinary proceedings under the Medical Registration Act.
How Did the Court Analyse the Issues?
The Court’s analysis began with the legal framework for professional misconduct under s 53(1)(d). It relied on the approach articulated in Low Cze Hong v Singapore Medical Council [2008] 3 SLR(R) 612, under which professional misconduct may be established where the conduct amounts to an intentional, deliberate departure from standards observed or approved by members of the profession of good repute and competence. The Court therefore focused on whether Dr Ang’s conduct was not merely negligent or suboptimal, but a departure of the relevant kind.
For the first charge, the Court agreed with the DT’s method of determining meaning. The statement’s content was not assessed in isolation; instead, it was interpreted objectively by considering the audience (a lay patient and family), the surrounding circumstances, and the context in which the statement was made. The Court accepted that a reasonable lay person in MT’s position would understand the “70% chance” as a meaningful probability that her disease would respond and be brought under control with the recommended treatment regimen.
On falsity and basis, the Court examined the medical premise underlying the “70%” figure. The DT had found that a 70% disease control rate was only achievable in patients with EGFR mutation. Because Dr Ang did not carry out EGFR analysis to ascertain MT’s EGFR status, he lacked the necessary clinical basis to make a confident representation of that magnitude. The Court treated the absence of EGFR testing as central: it meant that the “70%” figure was not grounded on the patient-specific information required to justify such a probability. The Court therefore upheld the DT’s conclusion that the statement was false and that Dr Ang had no reasonable basis for believing it to be true.
For the second charge, the Court addressed the omission of surgery. The patient’s cancer was described as cT3 N0 M0 (stage IIB) lung cancer. Surgery was a viable treatment option that ought to have been presented to MT. The Court’s reasoning emphasised patient-centred decision-making: where an alternative treatment option is viable, a doctor must inform the patient so that the patient can make an informed choice. The Court treated the failure to offer surgery not as a mere difference of clinical judgment, but as an intentional, deliberate departure from professional standards, given the viability of surgery and the importance of presenting alternatives.
On sentencing, the Court considered the SMC’s submission that the fine was manifestly inadequate. The Court’s approach reflected the disciplinary purpose of protecting the public and maintaining professional standards, while also ensuring proportionality. It considered that the misconduct involved misleading patient information about treatment efficacy and a failure to present a significant alternative option. These were not technical lapses; they went to the heart of informed consent and the patient’s ability to weigh options. The Court therefore assessed whether the DT’s aggregate fine adequately reflected the seriousness and consequences of the breaches.
What Was the Outcome?
The High Court dismissed Dr Ang’s appeal against conviction, upholding the DT’s findings on both charges. It also addressed the SMC’s appeal on sentence, evaluating whether the DT’s aggregate fine of S$25,000 was manifestly inadequate in light of the nature of the misconduct and its impact on patient decision-making.
Accordingly, the Court’s orders resulted in the disciplinary outcome being maintained (subject to any modification on sentence, if ordered). The practical effect was that Dr Ang remained convicted of professional misconduct on the two upheld charges, and the Court’s reasoning reinforced that doctors must provide accurate, patient-specific information and must present viable treatment alternatives.
Why Does This Case Matter?
Ang Peng Tiam is significant for practitioners because it clarifies how disciplinary tribunals and appellate courts will evaluate doctor-patient communications. The case demonstrates that a doctor’s verbal probability statements—especially those framed as high-confidence figures—will be interpreted objectively from the patient’s perspective. If the doctor lacks the clinical testing or patient-specific basis to support the stated probability, the statement may be treated as a false representation amounting to professional misconduct.
The decision also underscores the professional duty to present viable options. In modern clinical practice, informed consent is not merely a procedural step; it is a substantive requirement grounded in the patient’s right to understand meaningful alternatives. Where surgery is a viable option, failing to offer it can constitute a deliberate departure from accepted standards, even if the doctor proceeds with another treatment pathway.
For law students and medical professionals alike, the case provides a useful template for analysing professional misconduct under s 53(1)(d): (i) identify the relevant standard and whether the departure was intentional and deliberate, (ii) interpret impugned communications in context, (iii) assess whether the doctor had a reasonable basis for the statements made, and (iv) consider the seriousness of the breach when reviewing sentence. It also illustrates how delays in disciplinary proceedings may be relevant to overall fairness, though the core findings turned on the substantive misconduct.
Legislation Referenced
- Medical Registration Act (Cap. 174) (including s 53(1)(d))
- Medical Registration Act (Cap. 174, 2004 Rev Ed)
- Ethical Code (Singapore Ethical Code / Ethical Code referenced in the metadata)
Cases Cited
Source Documents
This article analyses [2017] SGHC 143 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.